# Efficacy and Safety of the Association Drugs in Patients With Allergic Dermatitis

> **NCT01125761** · PHASE3 · WITHDRAWN · sponsor: **Azidus Brasil**

## Conditions studied

- Dermatitis

## Interventions

- **DRUG:** dexamethasone 0.5 mg and 1.0 mg clemastine cream
- **DRUG:** Dexamethasone 0,5 mg cream

## Key facts

- **NCT ID:** NCT01125761
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-11
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2022-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01125761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01125761, "Efficacy and Safety of the Association Drugs in Patients With Allergic Dermatitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01125761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*